ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial

by Rose-Zerilli, Matthew J., Forster, Jade, Parker, Helen, Parker, Anton, Rodríguez, Ana E., Chaplin, Tracy, Gardiner, Anne, Steele, Andrew J., Collins, A., Young, Bryan D., Skowronska, Anna, Catovsky, Daniel, Stankovic, Tanja, Oscier, D.G, Strefford, Jonathan C.
Published 2014